Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

MATTHEW S DAVIDS

Allopathic & Osteopathic Physicians Internal Medicine Hematology & Oncology

NPI
1659541522
CMS profile
257015
Location
BOSTON, MA

General Payments · PY2018–2024

$725,644.76

  • Reported across 467 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$101,161.88

65 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
ABBVIE INC. $25,796.92 18
BeiGene Switzerland GmbH $24,540.17 6
Acerta Pharma LLC $21,394.10 17
Eli Lilly and Company $8,550.00 3
AstraZeneca UK Limited $6,246.92 6
Genentech USA, Inc. $3,800.00 2
Lilly USA, LLC $3,150.00 1
Genmab U.S., Inc. $2,735.02 3
E.R. Squibb & Sons, L.L.C. $2,160.20 3
BeiGene USA, Inc. $2,118.55 4
BeiGene, Ltd. $340.00 1
Genentech, Inc. $330.00 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $110,562.93 101
PY2019 $87,831.66 82
PY2020 $97,922.33 40
PY2021 $78,353.37 51
PY2022 $122,774.83 52
PY2023 $127,037.76 76
PY2024 $101,161.88 65

Payment records · PY2024 (65)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
ABBVIE INC. $2,000.00 02/08/2024 Consulting Fee Undisputed 01/23/2026 1103133447 CMS
ABBVIE INC. $1,600.00 05/28/2024 Consulting Fee Undisputed 01/23/2026 1103133449 CMS
ABBVIE INC. $1,600.00 05/28/2024 Consulting Fee Undisputed 01/23/2026 1103133451 CMS
ABBVIE INC. $1,600.00 05/28/2024 Consulting Fee Undisputed 01/23/2026 1103133453 CMS
ABBVIE INC. $2,400.00 05/28/2024 Consulting Fee Undisputed 01/23/2026 1103133455 CMS
ABBVIE INC. $1,600.00 05/28/2024 Consulting Fee Undisputed 01/23/2026 1103133457 CMS
ABBVIE INC. $1,600.00 05/30/2024 Consulting Fee Undisputed 01/23/2026 1103133459 CMS
ABBVIE INC. $1,600.00 06/05/2024 Consulting Fee Undisputed 01/23/2026 1103133461 CMS
ABBVIE INC. $1,600.00 06/10/2024 Consulting Fee Undisputed 01/23/2026 1103133463 CMS
ABBVIE INC. $15.93 06/12/2024 Food and Beverage Undisputed 01/23/2026 1103605956 CMS
ABBVIE INC. $53.11 06/12/2024 Food and Beverage Undisputed 01/23/2026 1103605958 CMS
ABBVIE INC. $5,600.00 08/13/2024 Consulting Fee Undisputed 01/23/2026 1103133465 CMS
ABBVIE INC. $400.00 08/21/2024 Consulting Fee Undisputed 01/23/2026 1103133467 CMS
ABBVIE INC. $4,000.00 09/18/2024 Consulting Fee Undisputed 01/23/2026 1103133469 CMS
ABBVIE INC. $29.88 09/18/2024 Travel and Lodging Undisputed 01/23/2026 1104182804 CMS
ABBVIE INC. $29.43 10/19/2024 Food and Beverage Undisputed 01/23/2026 1103605960 CMS
ABBVIE INC. $55.71 12/06/2024 Food and Beverage Undisputed 01/23/2026 1103605962 CMS
ABBVIE INC. $12.86 12/06/2024 Food and Beverage Undisputed 01/23/2026 1103605964 CMS
AstraZeneca Pharmaceuticals LP $2,055.00 01/28/2024 Consulting Fee Undisputed 01/23/2026 1110533268 CMS
AstraZeneca Pharmaceuticals LP $685.00 02/01/2024 Consulting Fee Undisputed 01/23/2026 1110555544 CMS
AstraZeneca Pharmaceuticals LP $4.66 02/09/2024 Food and Beverage Undisputed 01/23/2026 1110553546 CMS
AstraZeneca Pharmaceuticals LP $124.58 02/12/2024 Food and Beverage Undisputed 01/23/2026 1110547194 CMS
AstraZeneca Pharmaceuticals LP $25.12 02/13/2024 Food and Beverage Undisputed 01/23/2026 1110544775 CMS
AstraZeneca Pharmaceuticals LP $15.90 02/13/2024 Food and Beverage Undisputed 01/23/2026 1110551556 CMS
AstraZeneca Pharmaceuticals LP $24.52 03/14/2024 Travel and Lodging Undisputed 01/23/2026 1110539313 CMS
AstraZeneca Pharmaceuticals LP $14.00 03/14/2024 Travel and Lodging Undisputed 01/23/2026 1110544589 CMS
AstraZeneca Pharmaceuticals LP $5,480.00 05/27/2024 Consulting Fee Undisputed 01/23/2026 1110553434 CMS
AstraZeneca Pharmaceuticals LP $342.50 05/28/2024 Consulting Fee Undisputed 01/23/2026 1110546075 CMS
AstraZeneca Pharmaceuticals LP $48.94 06/14/2024 Food and Beverage Undisputed 01/23/2026 1110550338 CMS
AstraZeneca Pharmaceuticals LP $5,822.50 07/01/2024 Consulting Fee Undisputed 01/23/2026 1110532021 CMS
AstraZeneca Pharmaceuticals LP $1,370.00 08/15/2024 Consulting Fee Undisputed 01/23/2026 1110531003 CMS
AstraZeneca Pharmaceuticals LP $1,027.50 10/14/2024 Consulting Fee Undisputed 01/23/2026 1110554882 CMS
AstraZeneca Pharmaceuticals LP $118.88 12/07/2024 Food and Beverage Undisputed 01/23/2026 1110541103 CMS
AstraZeneca Pharmaceuticals LP $135.00 12/09/2024 Food and Beverage Undisputed 01/23/2026 1110534612 CMS
AstraZeneca Pharmaceuticals LP $4,100.00 12/23/2024 Consulting Fee Undisputed 01/23/2026 1110553186 CMS
AstraZeneca UK Limited $2,055.00 02/16/2024 Consulting Fee Undisputed 01/23/2026 1110537995 CMS
AstraZeneca UK Limited $21.75 06/15/2024 Food and Beverage Undisputed 01/23/2026 1110542845 CMS
AstraZeneca UK Limited $1,370.00 07/29/2024 Consulting Fee Undisputed 01/23/2026 1110555674 CMS
AstraZeneca UK Limited $1,370.00 08/19/2024 Consulting Fee Undisputed 01/23/2026 1110536276 CMS
AstraZeneca UK Limited $60.17 09/26/2024 Food and Beverage Undisputed 01/23/2026 1110548922 CMS
AstraZeneca UK Limited $1,370.00 10/24/2024 Consulting Fee Undisputed 01/23/2026 1110547968 CMS
BeiGene Switzerland GmbH $8,349.37 05/13/2024 Travel and Lodging Undisputed 01/23/2026 1120858085 CMS
BeiGene Switzerland GmbH $8,037.32 06/11/2024 Travel and Lodging Undisputed 01/23/2026 1120858087 CMS
BeiGene Switzerland GmbH $4,875.00 07/15/2024 Consulting Fee Undisputed 01/23/2026 1120858081 CMS
BeiGene Switzerland GmbH $117.52 07/15/2024 Travel and Lodging Undisputed 01/23/2026 1120858083 CMS
BeiGene Switzerland GmbH $3,000.00 07/16/2024 Consulting Fee Undisputed 01/23/2026 1120858089 CMS
BeiGene Switzerland GmbH $160.96 07/16/2024 Travel and Lodging Undisputed 01/23/2026 1120858091 CMS
BeiGene USA, Inc. $79.53 03/01/2024 Food and Beverage Undisputed 01/23/2026 1120858073 CMS
BeiGene USA, Inc. $53.95 05/13/2024 Food and Beverage Undisputed 01/23/2026 1120858077 CMS
BeiGene USA, Inc. $1,875.00 06/28/2024 Consulting Fee Undisputed 01/23/2026 1120858075 CMS
BeiGene USA, Inc. $110.07 10/02/2024 Food and Beverage Undisputed 01/23/2026 1120858079 CMS
BeiGene, Ltd. $340.00 01/17/2024 Consulting Fee Undisputed 01/23/2026 1120858071 CMS
E.R. Squibb & Sons, L.L.C. $346.00 05/28/2024 Consulting Fee Undisputed 01/23/2026 1101256429 CMS
E.R. Squibb & Sons, L.L.C. $1,799.20 06/04/2024 Consulting Fee Undisputed 01/23/2026 1101256431 CMS
E.R. Squibb & Sons, L.L.C. $15.00 12/06/2024 Food and Beverage Undisputed 01/23/2026 1101256509 CMS
Eli Lilly and Company $6,300.00 02/02/2024 Consulting Fee Undisputed 01/23/2026 1135179001 CMS
Eli Lilly and Company $1,350.00 07/01/2024 Consulting Fee Undisputed 01/23/2026 1135170626 CMS
Eli Lilly and Company $900.00 12/09/2024 Consulting Fee Undisputed 01/23/2026 1135184893 CMS
Genentech USA, Inc. $1,520.00 01/02/2024 Consulting Fee Undisputed 01/23/2026 1133065643 CMS
Genentech USA, Inc. $2,280.00 04/02/2024 Consulting Fee Undisputed 01/23/2026 1133065639 CMS
Genentech, Inc. $330.00 03/01/2024 Consulting Fee Undisputed 01/23/2026 1133065647 CMS
Genmab U.S., Inc. $217.31 09/24/2024 Travel and Lodging Undisputed 01/23/2026 1126829540 CMS
Genmab U.S., Inc. $80.21 09/25/2024 Food and Beverage Undisputed 01/23/2026 1126829542 CMS
Genmab U.S., Inc. $2,437.50 09/25/2024 Consulting Fee Undisputed 01/23/2026 1126829544 CMS
Lilly USA, LLC $3,150.00 11/04/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1135179003 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.